Ferrer Freeman & Company closes on $400 million secondary recapitalization with Morgan Stanley


Sixpoint Partners is pleased to announce that Ferrer Freeman & Company, LLC (“FFC”), a healthcare focused private equity firm based in Greenwich, CT, has executed a secondary recapitalization and extension of FFC Partners III, L.P. (“Fund III”), a 2004 vintage fund with $400 million in original commitments. To effect the transaction, FFC partnered with Morgan Stanley Alternative Investment Partners (“Morgan Stanley AIP”).

Transaction Overview

  • Morgan Stanley AIP’s participation is further validation of FFC’s growth capital strategy for investing in middle-market healthcare companies
  • As has been reported, following an extensive parallel due diligence process, Morgan Stanley AIP has committed to supporting FFC’s on-going investment activities
  • The transaction involved an innovative structure that provided Fund III limited partners with the opportunity to receive liquidity at a market premium or benefit from an extension of Fund III
  • The transaction received 100% LP approval

About Ferrer Freeman & Company
Ferrer Freeman & Company is a private equity firm located in Greenwich, CT, focused on making growth capital investments in healthcare companies. Since its founding in 1995, FFC has invested over $900 million in 36 portfolio companies across three institutional funds. FFC invests in established companies in the middle market with significant growth opportunities, backs entrepreneurial management teams, and leverages its comprehensive healthcare network and value creation model to accelerate growth and build market-leading and strategically valuable companies.

About Sixpoint Partners
Sixpoint Partners is a leading global investment bank focused on a diversified set of services and solutions for the middle-market private equity industry. Our core areas of focus include (i) primary fund placement, (ii) secondaries advisory and (iii) co-investments across a wide range of industries, strategies and geographies.